All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

132

Reset

132 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • GEN1042Phase 21 trial

    Genmab · Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)

  • GM103Phase 21 trial

    GeneMedicine Co., Ltd. · Head and Neck Cancer, Malignant Melanoma, Colorectal Cancer

  • GSK4418959Phase 21 trial

    GSK · Neoplasms, Colorectal, Solid Tumor, Colon Cancer

  • HSK42360-NaPhase 21 trial

    Haisco Pharmaceutical Group Co., Ltd. · Metastatic Colorectal Cancer (CRC)

  • ImofinostatABT-301, MPT0E028Phase 21 trial

    Anbogen Therapeutics, Inc. · Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic, Colorectal Cancer (CRC)

  • IMT-009Phase 21 trial

    Immunitas Therapeutics · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer

  • IOV-5001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Advanced Solid Tumors, Non-Small Cell Lung Cancer, Triple Negative Breast Cancer (TNBC)

  • IPN01194Phase 21 trial

    Ipsen · Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma

  • JMT203Phase 21 trial

    Shanghai JMT-Bio Inc. · Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia

  • JYP0015Phase 21 trial

    Guangzhou JOYO Pharma Co., Ltd · Solid Tumor, Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC)

  • leronlimabPRO 140Phase 21 trial

    CytoDyn, Inc. · Metastatic Colorectal Cancer (mCRC)

  • LG00313112Phase 21 trial

    LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • LPM6690176Phase 21 trial

    Luye Pharma Group Ltd. · Metastatic Colorectal Cancer (mCRC)

  • LUM015Phase 21 trial

    Lumicell, Inc. · Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer

  • LYL273Phase 21 trial

    Lyell Immunopharma, Inc. · Colorectal Cancer

  • MRG007Phase 21 trial

    Lepu Biopharma Co., Ltd. · Advanced Colorectal Cancer

  • NEO212POH-TMZPhase 21 trial

    Neonc Technologies, Inc. · Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult

  • NGM120Phase 21 trial

    NGM Biopharmaceuticals, Inc · Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia

  • RP-001Phase 21 trial

    Recurv Pharma Inc · Advanced Malignancies, Oncology, Colorectal Cancer

  • SOT109Phase 21 trial

    SOTIO Biotech a.s. · Colorectal Cancer (Locally Advanced or Metastatic)

  • SotevtamabAB-16B5Phase 21 trial

    Alethia Biotherapeutics · Metastatic Colorectal Cancer

  • SPH5030Phase 21 trial

    Shanghai Pharmaceuticals Holding Co., Ltd · Biliary Tract or Colorectal Cancer With Her2-positive/Mutated

  • STC-1010Phase 21 trial

    Brenus Pharma · Unresectable Metastatic Colorectal Cancer, Unresectable Locally Advanced Colorectal Cancer

  • SYS6062Phase 21 trial

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Gastric Cancer (GC), Colorectal Cancer (CRC)

  • TB511Phase 21 trial

    Twinpig Biolab, Inc. · NSCLC, Prostate Cancer, Colorectal Cancer

  • TH9619Phase 21 trial

    One-carbon Therapeutics AB · Solid Tumor, Colorectal Cancer (CRC), Squamous Cell Carcinoma of Head and Neck

  • TL938Phase 21 trial

    Teligene US · Colorectal Cancer Metastatic, Advanced Colorectal Cancer

  • VMD-102Single agentPhase 21 trial

    VM Discovery, Inc. · Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC)

  • WEF-001Phase 21 trial

    Auricula Biosciences Inc. · Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer

  • XP-102Phase 21 trial

    Xynomic Pharmaceuticals, Inc. · Cancer, BRAF V600 Mutation, Melanoma

  • XS-03Phase 21 trial

    Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · Colorectal Cancer, Metastatic Colorectal Cancer With RAS Mutation

  • XYA02Phase 21 trial

    XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer

NewerPage 3 of 3

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.